Fund III was backed by US university endowments, foundations, hospitals, and institutional investors.
The Series A funding round was led by Octopus Ventures, with additional participation from Fuel Ventures.
The investment saw support from People Ventures and Repeat Ventures, alongside lead investor Creadum.
The round was led by Axon Enterprise, with participation from Munkene AS.
The €5 million pre‑seed round was led by Balderton Capital, with participation from NP Hard.
The fresh round was backed by Simon Capital, Oyster Bay Venture Capital, EquityPitcher Ventures, and Backbone Ventures.
The round was backed by Novanta Inc., Inderhabs, Namarel Ventures, and Braincats Consulting.
The funding round was led by Spectrum Equity, with support from Visionaries Club and s16vc.